Target intelligence / Profile preview

Classical zinc-dependent histone deacetylase (HDAC) (HDAC)

Target
HDAC
Molecular classification
Enzyme, Histone modification, Hydrolase, Zinc-binding protein
01

Overview

Classical zinc-dependent histone deacetylases (HDACs) are a family of 11 enzymes that catalyze the removal of acetyl groups from lysine residues on both histone and non-histone proteins (UniProt, 2024). These enzymes are categorized into three classes based on their homology to yeast proteins: Class I (HDAC1, 2, 3, and 8), Class II (HDAC4, 5, 6, 7, 9, and 10), and Class IV (HDAC11) (NCBI Gene, 2024). By deacetylating histones, they promote a condensed chromatin state, which typically leads to the repression of gene transcription (PubMed: PMC7400110). Beyond epigenetics, they regulate the function of numerous cytoplasmic proteins involved in the cell cycle, apoptosis, and DNA repair (StatPearls: NBK559020). In many cancers, HDACs are overexpressed or aberrantly recruited to promoters, leading to the silencing of tumor suppressor genes (NIH National Cancer Institute, 2023). Pharmacological inhibition of these enzymes has proven effective in treating certain hematological malignancies by inducing cell cycle arrest and programmed cell death (FDA, 2024).

Other names
Zinc-dependent histone deacetylasesClassical HDACsHistone deacetylase family (Classes I, II, and IV)Metal-dependent HDACs
02

Mechanism of action

Inhibition of the zinc-dependent catalytic site of HDAC enzymes, preventing the removal of acetyl groups from lysine residues on histones and non-histone proteins, which results in hyperacetylation, chromatin relaxation, and the reactivation of silenced genes (StatPearls, 2023; PubMed: PMC3436371).

03

Biological functions

Gene expression regulationChromatin remodelingCell cycle regulationApoptosisProtein deacetylationDNA repair
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseAutoimmune disease
05

Safety considerations

ThrombocytopeniaNeutropeniaQT interval prolongationNausea and vomitingFatigueDiarrhea
06

Interacting drugs

Vorinostat

8 more in the full profile.

07

Biomarkers

Histone H3 acetylationHistone H4 acetylationp21 (WAF1/CIP1) expressionHR23B protein levels

Beyond the preview

Go deeper on Classical zinc-dependent histone deacetylase (HDAC) (HDAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Classical zinc-dependent histone deacetylase (HDAC) (HDAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call